Reference
Choi M, et al. T cell PTLD successfully treated with single-agent brentuximab vedotin first-line therapy. Transplantation 100: e8-e10, No. 3, Mar 2016. Available from: URL: http://doi.org/10.1097/TP.0000000000001099 - Germany
Rights and permissions
About this article
Cite this article
Brentuximab vedotin. Reactions Weekly 1600, 58 (2016). https://doi.org/10.1007/s40278-016-17143-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-17143-y